Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination

Long-term hemodialysis (HD) patients are considered vulnerable and at high-risk of developing severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection due to their immunocompromised condition. Since COVID-19 associated mortality rates are higher in HD patients, vaccination is crit...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Perez, Maria, Montes-Casado, Maria, Conde, Patricia, Cervera, Isabel, Baranda, Jana, Berges-Buxeda, Marcos J., Perez-Olmeda, Mayte, Sanchez-Tarjuelo, Rodrigo, Utrero-Rico, Alberto, Lozano-Ojalvo, Daniel, Torre, Denis, Schwarz, Megan, Guccione, Ernesto, Camara, Carmen, Llópez-Carratalá, M Rosario, Gonzalez-Parra, Emilio, Portoles, Pilar, Ortiz, Alberto, Portoles, Jose, Ochando, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983822/
https://www.ncbi.nlm.nih.gov/pubmed/35401504
http://dx.doi.org/10.3389/fimmu.2022.845882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983822/
https://www.ncbi.nlm.nih.gov/pubmed/35401504
http://dx.doi.org/10.3389/fimmu.2022.845882

Ejemplares similares